Prothena: Trading Below Cash, Key Clinical Readouts In Coming Year [Seeking Alpha]
Prothena Corporation plc - Ordinary Shares (PRTA)
Last prothena corporation plc - ordinary shares earnings: 2/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.prothena.com
Company Research
Source: Seeking Alpha
Prothena: Trading Below Cash, Key Clinical Readouts In Coming Year Summary Shares have fallen by 38% over the past year. I provide an operational overview and recap of management's presentation at Jefferies Healthcare Conference. There's significant genetic evidence for targeting a-synuclein via prasinezumab in Parkinson's disease, but current Phase 2 study is exploratory. PRX004 has potential points of differentiation in addressing ATTR Amyloidosis versus competitor progras, but is still early stage (multiple ascending dose study). Other positives here include big pharma partnerships and low valuation (trading below cash). That said, this is still a speculative name and proof of concept data is needed to provide more derisking. Shares of Ireland-based Prothena Corporation ( PRTA disclosed a 23.6% stake A quick glance at the company showed that it was trading for under the value of its cash position, with multiple irons in the fire including an intriguing program (partnered with Roche
Show less
Read more
Impact Snapshot
Event Time:
PRTA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PRTA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PRTA alerts
High impacting Prothena Corporation plc - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
PRTA
News
- Prothena Co. plc (NASDAQ: PRTA) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.MarketBeat
- Prothena Co. plc (NASDAQ: PRTA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $84.00 price target on the stock.MarketBeat
- Prothena Q3 Earnings Beat Estimates, Pipeline Progress in Focus [Yahoo! Finance]Yahoo! Finance
- Prothena (PRTA) Reports Q3 Loss, Misses Revenue Estimates [Yahoo! Finance]Yahoo! Finance
- Prothena Reports Third Quarter 2024 Financial Results and Business Highlights [Yahoo! Finance]Yahoo! Finance
PRTA
Earnings
- 11/12/24 - Beat
PRTA
Sec Filings
- 11/14/24 - Form SC
- 11/13/24 - Form SC
- 11/13/24 - Form SC
- PRTA's page on the SEC website